Tag Archives: FDA

FDA Expands Recalls to All Peanuts and Peanut Products from Blakely GA Plant

The Food and Drug Administration has expanded the recall of peanut products from the Peanut Corporation of America’s plant in Blakely GA after inspectors identified additional strains of Salmonella at the facility along with poor sanitation practices. The plant provides peanut butter and peanut paste to more than 70 food companies that manufacturer a wide variety of products from cookies to ice cream to dog food.  Hundreds of products have been voluntarily recalled by those companies.  So far, there is no evidence that any retail peanut butter is contaminated.  The Centers for Disease Control has not had reports of Salmonella infection from strains other than Typhimurium.

Find Peanut Butter Product Recalls

Salmonella Outbreak Update The Food and Drug Administration has a website where consumers can search for information on foods recalled because of potential Salmonella contamination. You can search by brand name, UPC, product description (for example, crackers with peanut butter), or any combination of the three. The FDA has traced the source of Salmonella Typhimurium outbreak to peanut butter and peanut paste manufactured by the Peanut Corporation of America in their plant in Blakely, Georgia.  The FDA recommends that consumers avoid all commercially-produced food made with peanut butter until more information is known about the extent of contamination.

FDA Recommends Consumers Avoid Products Containing Peanut Butter

Salmonella Update With many new recalls of foods containing peanut butter or peanut paste, the Food and Drug Administration is now recommending that consumers avoid all commercially prepared foods made with peanut butter or eating peanut butter served in institutional settings. Current recalls, listed on the FDA website, include a variety of cookies, candies, sandwich crackers, ice cream, and frozen pastry with many different labels.

Kellogg Removes Peanut Butter Crackers from Store Shelves

Salmonella Update The Kellogg Company has put a hold on shipping its sandwich crackers with peanut butter.  It is removing them from retail store shelves and asks consumers not to eat them until further notice that their safety is assured. Products affected include Austin® and Keebler® branded Toasted Peanut Butter Sandwich Crackers, Peanut Butter and Jelly Sandwich Crackers, Cheese and Peanut Butter Sandwich Crackers, and Peanut Butter-Chocolate Sandwich Crackers

King Nut Peanut Butter Recalled Because of Salmonella

The Food and Drug Administration and the King Nut Companies have announced a recall of King Nut Peanut Butter after Salmonella was found in an open five pound tub of peanut butter.  King Nut is also recalling Parnell’s Pride peanut butter, which is manufactured by the same company that makes King Nut. King Nut Companies distribute both the King Nut and Parnell’s Pride brands of  peanut butter for institutional use.  However, they are both manufactured by the Peanut Corporation of America.  Parnell’s Pride is also distributed by other companies. King Nut does not sell peanut butter directly to consumers, but distributes it to food service accounts only.  None of the

Another Ethex recall: 2 Mg Hydromorphone

On December 23, 2008 Ethex Corporation recalled one lot of 2 mg hydromorphone tablets because it may contain oversized pills. Hydromorphone is used to manage pain.  Too high a dose could cause difficulty breathing, excessive sedation, or low blood pressure.  Patients taking hydromorphone who experience these adverse effects should contact their doctor immediately.  If the patient cannot breathe or doesn’t respond, call 911. The lot recalled is #90219.  The round tablets are blue with a script “E” on one side and a “2″ on the other side.  Hydromorphone is also marketed by Abbott with the brandname Dilaudid®

C.B. Fleet Recalls Its Over-the-Counter Phospho-soda Products

On December 11, 2008 the C.B. Fleet Company voluntarily recalled all their over-the-counter oral sodium phosphate products including Fleet Phospho-soda® and Fleet EZ-Prep™ Bowel Cleansing System. The recall follows the Food and Drug Administration safety alert on Thursday connecting oral sodium phosphate bowel cleansers to acute phosphate nephropathy.

Leucovorin Shortage Threatens Colorectal Cancer Treatment

The Food and Drug Administration is reporting shortages of leucovorin calcium, used to enhance the effectiveness of 5-FU (fluorouracil) in treating colorectal cancer.  The reason the FDA gives for the shortage is “Manufacturing Delays.” Leucovorin is supplied by Teva Pharmaceuticals and Bedford Laboratories, and the FDA directs consumers to contact them for more information. According to a bulletin from the American Society of Health System Pharmacists (ASHP), “Leucovorin calcium lyophilized powder is on back order and the company cannot estimate a release date.” In addition, ASHP has been told, “The manufacturers will not provide a reason for the shortage.” ASHP updated their information with personal communications with the manufacturers on

FDA Requires Black Box Warnings for Bowel Cleansers Visicol and OsmoPrep

On November 11, 2008 the Food and Drug Commission issued an alert about the safe use of bowel cleansing products that contain oral sodium phosphate. The FDA is requiring that the manufacturers of prescription Visicol® and OsmoPrep® put Black Box warnings on the labels for these products.  In addition, the FDA intends to change labeling for over-the-counter oral sodium phosphate bowel preps including Fleet Phospho-Soda. New FDA labeling for over-the-counter sodium phosphate products will say that they should not be used for bowel cleansing and will address their safe use as laxatives. The alert follows more than 20 reports of acute phosphate nephropathy, a kidney injury that can cause permanent

More ETHEX Generic Medicine Recalls

ETHEX Corporation has recalled more lots of generic medicines because some pills may be oversized.  In addition to previous recalls of morphine sulfate and dextroamphetamine, the new recall includes two cardiac drugs and additional lots and dosages of morphine and dextroamphetamine. There is a possibility that some tablets may be oversized and contain up to double the amount of active medicine.  Overdoses can cause serious medical problems including difficulty breathing and low blood pressure for morphine and rapid heart beat and high blood pressure for dextroamphetamine. If you or the patient you are caring for has difficulty breathing, faints, becomes unresponsive, or has other signs of morphine overdose, call 911